logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Retina Associates, LLC

Verified
+19138317400
Source: Site record.
https://www.kcretina.com/retina-specialists-lenexa-ks

Basic Information

Site Overview

Source: Human-provided.

Retina Associates of Greater Kansas City is a leading specialty ophthalmology practice dedicated to the diagnosis, treatment, and research of retinal, macular, and vitreous diseases. With multiple locations across Kansas and Missouri, including its primary center in Lenexa, the practice provides advanced care for conditions such as age-related macular degeneration (AMD), diabetic retinopathy, retinal tears and detachments, retinal vein and artery occlusions, and other complex retinal disorders. Staffed by a team of highly trained, board-certified retina specialists and surgeons, Retina Associates combines cutting-edge diagnostic technology, innovative treatment options, and active participation in clinical research to deliver exceptional patient outcomes. As part of Retina Consultants of America, the organization is committed to preserving and restoring vision while advancing the future of retinal care through research, education, and patient-centered service.

Source: Trial-derived.
20Total Trials
Source: Trial-derived.
0Recruiting Trials
Source: Trial-derived.
4Active Trials
Source: Trial-derived.
13Completed Trials
Source: Trial-derived.
23Unique Conditions
Source: Trial-derived.
10Unique Sponsors

Conditions

Source: Trial-derived. Diabetic Macular Edema (4)Source: Trial-derived. wAMD (3)Source: Trial-derived. Wet Age-related Macular Degeneration (3)Source: Trial-derived. AMD (2)Source: Trial-derived. CNV (2)Source: Trial-derived. Macular Edema (2)Source: Trial-derived. nAMD (2)Source: Trial-derived. Neovascular Age-related Macular Degeneration (2)

Sponsors

Source: Trial-derived. Hoffmann-La Roche (9)Source: Trial-derived. Kodiak Sciences Inc (5)Source: Trial-derived. AbbVie (2)Source: Trial-derived. REGENXBIO Inc. (2)Source: Trial-derived. Bayer (1)Source: Trial-derived. Chugai Pharmaceutical (1)Source: Trial-derived. EyePoint Pharmaceuticals, Inc. (1)Source: Trial-derived. Novartis Pharmaceuticals (1)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Optical coherence tomography (OCT)
Source: AI-inferred. ETDRS 4 m visual-acuity lane
Source: AI-inferred. Fundus photography
Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravitreal injection
Source: AI-inferred. Surgery / operating room

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Anterior chamber paracentesis (aqueous humor sampling)
Source: AI-inferred. Best-corrected visual acuity testing
Source: AI-inferred. Fluorescein angiography
Source: AI-inferred. Fundus fluorescein angiography
Source: AI-inferred. Letter-chart visual acuity testing
Source: AI-inferred. Ocular implant refill-exchange procedure
Source: AI-inferred. Specular microscopy (corneal endothelial cell imaging)
Source: AI-inferred. Subretinal gene therapy delivery